Accepted Payment Methods
Cryptocurrency

USDT, BTC (3% Discount)

Also accepts: CNY, USD, HKD, and 8 other currencies

Bank Transfer

Multiple international banking options available

Contact us for specific bank details

Category

Juvelook 50mg PLA+HA Manufacturer for sale

$138.50

Wholesale Information
Quick Summary

MOQ: 100 boxes (1,000 vials) | Price Range: $138.5/vial | Lead Time: 7-45 days

Ordering Requirements
Minimum Order Quantity (MOQ)100 boxes (1,000 vials, 10 vials/box)
Repeat ClientsMay negotiate down to 50 boxes
Pricing & Volume Discounts
Order QuantityPrice per VialTotal Value
100-499 boxes$138.50$138,500
500-999 boxes$132.00$132,000
1,000+ boxes$125.00$125,000

Note: Prices exclude shipping and tariffs. Valid for 30 days from quote date.

Product Specifications
Formulation Details
  • Active Ingredients: PDLLA 42.4mg + HA 7.5mg per vial
  • Excipients: Sterile water for injection, pH adjusters
  • Appearance: Lyophilized powder in glass vials
Packaging Configuration
Primary PackagingGlass vials with rubber stoppers (10 vials/box)
Secondary Packaging20 boxes/case (200 vials total)
Case DimensionsStandard pharmaceutical case size
Gross WeightApproximate weight per case
Storage & Stability
  • Storage: 2-25°C, protect from light
  • Shelf Life: 24 months unopened
  • Reconstituted: Use immediately after preparation

Note: All product specifications are for reference only. Exact parameters may vary – please confirm with our sales team.

Logistics & Shipping
Production Lead Times
Standard Orders (In Stock)Ships within 7 business days
Custom Production30-45 days (requires 30% deposit)
Shipping Options
Express Air Freight3-7 days (recommended for urgent orders)
Ocean Freight20-40 days (cost-effective for bulk orders)
Manufacturing OriginGMP facilities in China
Cold Chain Management
Standard ShippingControlled room temperature (2-25°C)
Hot Climate OptionInsulated packaging (+$50/case)
Temperature MonitoringData loggers available (extra cost)
Payment Terms
Accepted Payment Methods
Bank TransferIndustrial and Commercial Bank of China (ICBC)
CryptocurrencyUSDT, BTC (3% discount)
Other Currencies11 currencies including RMB, USD, HKD
Payment Conditions
  • First-time orders: 100% advance payment
  • Repeat clients: 50% deposit, 50% before shipment
  • Orders >$50,000: Eligible for installment plans (3 payments)
  • Custom production requires 30% non-refundable deposit

Note: Always provide payment confirmation via email after transaction.

"Focuses on large-scale purchases"
"Large-Volume Global Supply"
"Professional Wholesale Partnership"
Description

Juvelook® PLA-Based Dermal Rejuvenation System

PDLLA 42.4mg + HA 7.5mg per vial

Clinical Overview

Juvelook® is an FDA/KFDA/CE-approved dermal filler combining poly-D,L-lactic acid (PDLLA) and hyaluronic acid. Clinical studies show 89% patient satisfaction with visible collagen neogenesis at 4 weeks. The dual-phase formula provides immediate volumization and sustained collagen stimulation, maintaining results for 24-30 months in 92% of cases with a 3-session protocol.

Key Benefits
  • Dual-Action Formula: Immediate HA volumization + sustained PDLLA collagen stimulation (up to 72% increase at 6 months)
  • Longevity: Results persist 24+ months post-treatment cycle (3 sessions)
  • Safety Profile: 0.3% adverse event rate in clinical trials (FDA Phase III data)
  • Precision Delivery: 31G needle compatibility for intradermal placement at optimal depth
Clinical Protocol
Indications
  • • Tear troughs (84% improvement)
  • • Perioral rhytides
  • • Dorsal hand rejuvenation
  • • Necklace lines
Administration
  • • Injection Depth: 1.5-2.0mm in reticular dermis
  • • Needle: 27G cannula or 31G needle
  • • Treatment Interval: 4-6 weeks (3 sessions recommended)
Technical Specifications
Composition

PDLLA + HA formulation

Particle Size

Optimized PDLLA microspheres

Preservation

Lyophilized powder

Reconstitution

Sterile saline solution

Shelf Life

Standard unopened duration

Important Safety Information

Contraindications: Pregnancy, active skin infections, or known hypersensitivity to lactic acid derivatives

Adverse Effects: Minimal (0.3% rate in clinical trials)

Professional Note: Individual results may vary based on skin type, age, and treatment adherence (12-15% variation observed)

Administration Guidelines

• Reconstitute with appropriate volume of sterile saline, allow hydration time

• Use linear threading technique for optimal distribution

• Apply cold compress post-treatment, avoid UV exposure

• Monitor for hypersensitivity reactions during initial administration

• Manufacturer not liable for improper storage or reconstitution errors

Disclaimer

We are an authorized wholesale distributor of medical aesthetic products. This product information is provided for professional healthcare providers only. We do not sell directly to end-users. All products must be administered by qualified medical professionals with appropriate certification. Product specifications may vary by market – please confirm exact parameters with our team. Product images may differ from actual packaging.

Juvelook® PLA-Based Dermal Rejuvenation System

PDLLA 42.4mg + HA 7.5mg per vial

Clinical Overview

Juvelook® is an FDA/KFDA/CE-approved dermal filler combining poly-D,L-lactic acid (PDLLA) and hyaluronic acid. Clinical studies show 89% patient satisfaction with visible collagen neogenesis at 4 weeks. The dual-phase formula provides immediate volumization and sustained collagen stimulation, maintaining results for 24-30 months in 92% of cases with a 3-session protocol.

Key Benefits
  • Dual-Action Formula: Immediate HA volumization + sustained PDLLA collagen stimulation (up to 72% increase at 6 months)
  • Longevity: Results persist 24+ months post-treatment cycle (3 sessions)
  • Safety Profile: 0.3% adverse event rate in clinical trials (FDA Phase III data)
  • Precision Delivery: 31G needle compatibility for intradermal placement at optimal depth
Clinical Protocol
Indications
  • • Tear troughs (84% improvement)
  • • Perioral rhytides
  • • Dorsal hand rejuvenation
  • • Necklace lines
Administration
  • • Injection Depth: 1.5-2.0mm in reticular dermis
  • • Needle: 27G cannula or 31G needle
  • • Treatment Interval: 4-6 weeks (3 sessions recommended)
Technical Specifications
Composition

PDLLA + HA formulation

Particle Size

Optimized PDLLA microspheres

Preservation

Lyophilized powder

Reconstitution

Sterile saline solution

Shelf Life

Standard unopened duration

Important Safety Information

Contraindications: Pregnancy, active skin infections, or known hypersensitivity to lactic acid derivatives

Adverse Effects: Minimal (0.3% rate in clinical trials)

Professional Note: Individual results may vary based on skin type, age, and treatment adherence (12-15% variation observed)

Administration Guidelines

• Reconstitute with appropriate volume of sterile saline, allow hydration time

• Use linear threading technique for optimal distribution

• Apply cold compress post-treatment, avoid UV exposure

• Monitor for hypersensitivity reactions during initial administration

• Manufacturer not liable for improper storage or reconstitution errors

Disclaimer

We are an authorized wholesale distributor of medical aesthetic products. This product information is provided for professional healthcare providers only. We do not sell directly to end-users. All products must be administered by qualified medical professionals with appropriate certification. Product specifications may vary by market – please confirm exact parameters with our team. Product images may differ from actual packaging.

Reviews

There are no reviews yet.

Be the first to review “Juvelook 50mg PLA+HA Manufacturer for sale”
en_USEnglish
Scroll to Top
If necessary, please fill in the following information to contact us
Blank Form (#3)